Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma

Molecular Cancer Research

Volumn 2, Issue 7, 2004, Pages 387-394

  Almgren, Malin A E ^a,b   Henriksson, K Cecilia E ^a,b   Fujimoto, Jennifer ^c   Chang, Christina L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A; RETINOIC ACID;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; CELL ADHESION; CELL MIGRATION; CELL SURVIVAL; CLONING; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INCIDENCE; LUNG METASTASIS; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TUMOR XENOGRAFT; WILD TYPE;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CLONE CELLS; DISEASE MODELS, ANIMAL; HUMANS; LUNG NEOPLASMS; MICE; MICE, SCID; MUTATION; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NUCLEOSIDE-DIPHOSPHATE KINASE; TRANSFECTION;

ANIMALIA;

EID: 3543149047     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Gilles AM, Presecan E, Vonica A, et al. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991;266:8784-9.
2. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-4.
3. Backer JM, Mendola CE, Kovesdi I, et al. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 1993;8:497-502.
4. Hartsough MT, Steeg PS. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000;32:301-8.
5. Leone A, Seeger RC, Hong CM, et al. Evidence for nm23 RNA over-expression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993;8:855-65.
6. Hailat N, Keim DR, Melhem RF, et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 1991;88:341-5.
7. Oda Y, Naka T, Takeshita M, et al. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Hum Pathol 2000;31:709-16.
8. Nakamori S, Ishikawa O, Ohhigashi H, et al. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 1993;11:151-8.
9. Nakamori S, Ishikawa O, Ohigashi H, et al. Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms. Int J Pancreatol 1993;14:125-33.
10. Alvarado CS, London WB, Look AT, et al. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 2000;22:197-205.
11. Perez CA, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a Children's Cancer Group study. J Clin Oncol 2000;18:18-26.
12. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73.
13. Lastowska M, Van Roy N, Bown N, et al. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines. Genes Chromosomes Cancer 1998;23:116-22.
14. Abel F, Ejeskar K, Kogner P, et al. Gain of chromosome arm 17q is associated with unfavorable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24. Br J Cancer 1999;81:1402-9.
15. Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999;340:1954-61.
16. Takeda O, Handa M, Uehara T, et al. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on lp in neuroblastomas. Br J Cancer 1996;74:1620-6.
17. Chang CL, Zhu XX, Thoraval DH, et al. Nm23-H1 mutation in neuroblastoma. Nature 1994;370:335-6.
18. Feder MK, Gilbert F. Clonal evolution in a human neuroblastoma. J Natl Cancer Inst 1983;70:1051-6.
19. Brodeur GM, Sawada T, Tsuchida Y, et al. Neuroblastoma. Amsterdam: Elsevier Science B.V.; 2000.
20. Zaizen Y, Taniguchi S, Suita S. The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression. J Pediatr Surg 1998;33:1765-70.
21. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
22. Lacombe ML, Sastre-Garau X, Lascu I, et al. Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumors. Eur J Cancer 1991;27:1302-7.
23. Keim D, Hailat N, Melhem R, et al. Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 1992;89:919-24.
24. Giannini G, Dawson MI, Zhang X, et al. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells. J Biol Chem 1997;272:26693-701.
25. Mena MA, Casarejos MJ, Estrada C, et al. Effects of retinoic acid on NB 69 human neuroblastoma cells and fetal rat mid brain neurons. J Neural Transm Park Dis Dement Sect 1994;8:85-97.
26. Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 2003;169:1122-33.
27. Okamoto T, Iwase K, Niu R. Expression and localization of nm23-H1 in the human placenta. Arch Gynecol Obstet 2002;266:1-4.
28. Ni X, Gu S, Dai J, et al. Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1. J Hum Genet 2003;48:96-100.
29. MacDonald NJ, Freije JMP, Stracke ML, et al. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J Biol Chem 1996;271:25107-16.
30. Kantor JD, McCormick B, Steeg PS, et al. Inhibition of cell motility after nm 23 transfection of human and murine tumor cells. Cancer Res 1993;53:1971-3.
31. Chang CL, Strahler JR, Thoraval DH, et al. A nucleoside diphosphate kinase A (nm23-H1) serine 12→glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Oncogene 1996;12:659-67.
32. Freije JM, Blay P, MacDonald NJ, et al. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 1997;272:5525-32.
33. Wagner PD, Steeg PS, Vu ND. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci USA 1997;94:9000-5.
34. Lascu I, Schaertl S, Wang C, et al. A point mutation of human nucleoside diphosphate kinase A found in aggressive neuroblastoma affects protein folding. J Biol Chem 1997;272:15599-602.
35. Otsuki Y, Tanaka M, Yoshii S, et al. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA 2001;98:4385-90.
36. Habets GG, Scholtes EH, Zuydgeest D, et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994;77:537-49.
37. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004;265:23-32.
38. Fournier HN, Dupe-Manet S, Bouvard D, et al. Integrin cytoplasmic domain-associated protein 1α (1CAP-1α) interacts directly with the metastasis suppresxsor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J Biol Chem 2002;277:20895-902.
39. Degani S, Balzac F, Brancaccio M, et al. The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading. J Cell Biol 2002;156:377-87.
40. Chang DD, Wong C, Smith H, et al. ICAP-1, a novel β1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of β1 integrin. J Cell Biol 1997;138:1149-57.
41. Amendola R, Martinez R, Negroni A, et al. DR-nm23 gene expression in neuroblastoma cells: relationship to integrin expression, adhesion characteristics, and differentiation. J Natl Cancer Inst 1997;89:1300-10.
42. Reynolds CP, Lemons RS. Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 2001;15:867-910.
43. Peverali FA, Orioli D, Tonon L, et al. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 1996;12:457-62.
44. Zhu J, Tseng YH, Kantor JD, et al. Interaction of the ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. Proc Natl Acad Sci USA 1999;96:14911-8.
45. Leeuwen FN, Kain HE, Kammen RA, et al. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho. J Cell Biol 1997;139:797-807.
46. Ward Y, Yap SF, Ravichandran V, et al. The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. J Cell Biol 2002;157:291-302.
47. Backer MV, Kamel N, Sandoval C, et al. Overexpression of NM23-1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuli. Anticancer Res 2000;20:1743-9.